Paul Nguyen, MD
Radiation Oncology · Boston, MANPI 1750315743
Payments from drug & device makers
Across 373 payments — averaging $14,497 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$4.8M
- Boston Scientific$518K
- Augmenix, Inc.$54K
- Bayer$21K
- Novartis$12K
- Janssen Global Services, LLC$9K
- plus $11K from 5 others
Across 2 payments — averaging $562.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Pharma AG$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 95 | $4,782,687 |
| Boston Scientific | 231 | $518,008 |
| Augmenix, Inc. | 3 | $54,370 |
| Bayer | 23 | $20,945 |
| Novartis | 10 | $11,926 |
| Janssen Global Services, LLC | 3 | $8,640 |
| Astellas Pharma Global Development | 1 | $5,627 |
| Janssen Scientific Affairs, LLC | 2 | $2,140 |
| Blue Earth Diagnostics | 3 | $2,057 |
| Amgen | 1 | $1,029 |
| Accuray Incorporated | 1 | $56 |
How this compares
$5,407,485 in reported general payments places this provider in the 95th percentile of 200 radiation oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Boston
- Alice HoBoston$6.3M
- Daphne Haas-KoganBoston$5.3M
- Martin KingBoston$3.9M
- Anthony DamicoBoston$2.9M
- Theodore HongBoston$2.9M
- Peter OrioBoston$1.9M
- Jonathan SchoenfeldBoston$1.7M
- Brian AlexanderBoston$610K
- Jennifer WoBoston$506K
- Jonathan LeemanBoston$487K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.